BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 20067380)

  • 1. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.
    Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK
    Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
    Gruszka A; Zielinski GM; Kunert-Radek J
    J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
    Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M
    Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma.
    Kishida M; Otsuka F; Kataoka H; Yokota K; Oishi T; Yamauchi T; Doihara H; Tamiya T; Mimura Y; Ogura T; Makino H
    Endocr J; 2000 Dec; 47(6):731-8. PubMed ID: 11228048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Fukuhara N; Horiguchi K; Nishioka H; Suzuki H; Takeshita A; Takeuchi Y; Inoshita N; Yamada S
    Endocr J; 2015; 62(1):21-7. PubMed ID: 25273395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A challenging TSH/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review.
    Yoon JH; Choi W; Park JY; Hong AR; Kim SS; Kim HK; Kang HC
    BMC Endocr Disord; 2021 Aug; 21(1):177. PubMed ID: 34461869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
    Caron P; Gerbeau C; Pradayrol L; Simonetta C; Bayard F
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Octreotide in the diagnosis and treatment of pituitary thyrotropin-secreting adenoma].
    Chen S; Li M; Lian XL; Zeng ZP; Dai WX; Li F; Yu W; Wang RZ
    Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):910-3. PubMed ID: 17313878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report.
    Yang J; Liu S; Yang Z; Shi YB
    Medicine (Baltimore); 2017 Dec; 96(50):e8912. PubMed ID: 29390279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P; Díez JJ
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid--a case report and surgical strategy.
    Ohta S; Nishizawa S; Oki Y; Namba H
    Pituitary; 2001 Sep; 4(4):271-4. PubMed ID: 12501979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
    Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
    Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of follicular thyroid carcinoma in a patient with thyrotropin-secreting pituitary adenoma.
    Poggi M; Monti S; Pascucci C; Toscano V
    Am J Med Sci; 2009 Jun; 337(6):462-5. PubMed ID: 19390430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
    J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
    Fukuda T; Yokoyama N; Tamai M; Imaizumi M; Kimura H; Tominaga T; Ashizawa K; Kiriyama T; Yoshimine H; Ohishi K; Eguchi K
    Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.